Yehonatan Levin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yehonatan Levin has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Amir Erez
Hebrew University of Jerusalem
2 shared publications Ateret Gordon
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
2 shared publications- Lilach Zelik
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
2 shared publications Meital Nuriel-Ohayon
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
2 shared publicationsMichal Werbner
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
2 shared publicationsMor Zigdon
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
2 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (11) , 3268-3284
Disentangling microbiota-dependent and -independent impacts of antibiotics on host physiology
Antibiotics are believed to affect host physiology by altering the gut microbiota. However, it remains unclear which effects of antibiotics are microbiota dependent and which are microbiota independent. Here we present a resource encompassing host and microbiota responses to antibiotic treatment and a computational tool with which to analyse them. Metagenomic and transcriptomic analyses of conventional and germ-free mice revealed that antibiotic administration routes and their combinations affect host and microbiota responses. We developed CompoRes—a computational tool that distinguishes the microbiota-independent impact of antibiotic-induced perturbations, revealing that antibiotics directly impact host physiology. We found that diurnal expression of major histocompatibility complex class II in the mouse colon is controlled by glucose via feeding. This pattern was lost during antibiotic treatment as vancomycin altered feeding behaviour in a microbiota-independent and evolutionarily conserved manner. Together, our study establishes a direct, non-microbial pathway by which antibiotics reshape host immunity and circadian physiology.
- 19 October 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (11) , 3268-3284
Open AccessDisentangling microbiota-dependent and -independent impacts of antibiotics on host physiology
Antibiotics are believed to affect host physiology by altering the gut microbiota. However, it remains unclear which effects of antibiotics are microbiota dependent and which are microbiota independent. Here we present a resource encompassing host and microbiota responses to antibiotic treatment and a computational tool with which to analyse them. Metagenomic and transcriptomic analyses of conventional and germ-free mice revealed that antibiotic administration routes and their combinations affect host and microbiota responses. We developed CompoRes—a computational tool that distinguishes the microbiota-independent impact of antibiotic-induced perturbations, revealing that antibiotics directly impact host physiology. We found that diurnal expression of major histocompatibility complex class II in the mouse colon is controlled by glucose via feeding. This pattern was lost during antibiotic treatment as vancomycin altered feeding behaviour in a microbiota-independent and evolutionarily conserved manner. Together, our study establishes a direct, non-microbial pathway by which antibiotics reshape host immunity and circadian physiology.
- Open Access
- 13 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (37) , eadp4119
Antibiotics damage the colonic mucus barrier in a microbiota-independent manner
Antibiotic use is a risk factor for development of inflammatory bowel diseases (IBDs). IBDs are characterized by a damaged mucus layer, which does not separate the intestinal epithelium from the microbiota. Here, we hypothesized that antibiotics affect the integrity of the mucus barrier, which allows bacterial penetrance and predisposes to intestinal inflammation. We found that antibiotic treatment led to breakdown of the colonic mucus barrier and penetration of bacteria into the mucus layer. Using fecal microbiota transplant, RNA sequencing followed by machine learning, ex vivo mucus secretion measurements, and antibiotic treatment of germ-free mice, we determined that antibiotics induce endoplasmic reticulum stress in the colon that inhibits colonic mucus secretion in a microbiota-independent manner. This antibiotic-induced mucus secretion flaw led to penetration of bacteria into the colonic mucus layer, translocation of microbial antigens into circulation, and exacerbation of ulcerations in a mouse model of IBD. Thus, antibiotic use might predispose to intestinal inflammation by impeding mucus production.
- 13 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (37) , eadp4119
Open AccessAntibiotics damage the colonic mucus barrier in a microbiota-independent manner
Antibiotic use is a risk factor for development of inflammatory bowel diseases (IBDs). IBDs are characterized by a damaged mucus layer, which does not separate the intestinal epithelium from the microbiota. Here, we hypothesized that antibiotics affect the integrity of the mucus barrier, which allows bacterial penetrance and predisposes to intestinal inflammation. We found that antibiotic treatment led to breakdown of the colonic mucus barrier and penetration of bacteria into the mucus layer. Using fecal microbiota transplant, RNA sequencing followed by machine learning, ex vivo mucus secretion measurements, and antibiotic treatment of germ-free mice, we determined that antibiotics induce endoplasmic reticulum stress in the colon that inhibits colonic mucus secretion in a microbiota-independent manner. This antibiotic-induced mucus secretion flaw led to penetration of bacteria into the colonic mucus layer, translocation of microbial antigens into circulation, and exacerbation of ulcerations in a mouse model of IBD. Thus, antibiotic use might predispose to intestinal inflammation by impeding mucus production.